6th Circuit pauses CFPB open banking rule appeals pending rulemaking

6th Circuit pauses CFPB open banking rule appeals pending rulemaking

GENIUS Act State Regulatory Regime Substantially Similar Determination Framework

Treasury issued its first proposed rule under the GENIUS Act (enacted July 2025) implementing section 4(c), which establishes principles for determining whether state-level payment stablecoin regulatory regimes are "substantially similar" to the federal framework. The proposal permits issuers with up to $10 billion consolidated total outstanding issuance to opt for state regulation if approved by the Stablecoin Certification Review Committee. Comments are due June 2, 2026.

Delaware Stablecoin Licensing and Digital Asset Framework

Delaware senators introduced SB19 (Delaware Payment Stablecoins Act) and SB16 (Delaware Banking Modernization Act) on March 23, 2026, proposing a state licensing and regulatory framework for stablecoin issuers and digital asset service providers. The bills align with the federal GENIUS Act requirements, including 1:1 reserve backing, anti-money laundering obligations, and consumer disclosures.

Tennessee Insurance Division NAIC Reaccreditation

The Tennessee Department of Commerce and Insurance announced that its Insurance Division received reaccreditation from the National Association of Insurance Commissioners (NAIC). The five-year reaccreditation confirms that Tennessee's insurance regulatory framework meets NAIC financial solvency oversight standards for regulating multi-state insurers. Tennessee currently has 327,685 active licensed insurance producers and domestic insurers wrote $24 billion in premium volume in 2024.

Contractor Fraud Warning After Severe Weather

Oklahoma Attorney General Gentner Drummond issued a consumer alert warning homeowners about contractor fraud following severe weather. The alert provides six tips to avoid scams, including verifying contractor credentials, getting multiple written estimates, and being cautious of upfront payment demands. The Consumer Protection Unit can be reached at 1-833-681-1895.

Construction Company Sued for Whistleblower Retaliation

The Department of Labor filed suit against Stone Hill Excavation LLC and its successor Split Rock Sand & Gravel in U.S. District Court for the District of South Dakota for allegedly violating whistleblower protection provisions under the Occupational Safety and Health Act. OSHA determined the company wrongfully terminated an employee two days after reporting a severe work-related injury involving second- and third-degree burns. The suit seeks reinstatement, back wages, and $100,000 in punitive damages.

Kawatachi v. Parrish - Certiorari Accepted

The Hawaii Supreme Court accepted the certiorari application in Kawatachi v. Parrish (SCWC-23-0000701). The case involves the Hawaii Civil Rights Commission and concerns disputed security deposits exceeding $5 million. The matter will be scheduled for oral argument before the state's highest court.

Quach v. State - Certiorari Application Denied

The Hawaii Supreme Court rejected Toan Quach's application for writ of certiorari challenging his criminal conviction. The five-justice court (with Justice Ginoza dissenting) denied review without explanation. The certiorari denial means the Intermediate Court of Appeals decision stands and the criminal case proceeds to final resolution.

Botteh v. Eat Just, Inc. - Removal from State Court

Eat Just, Inc. filed a Notice of Removal on April 6, 2026, removing the civil case Botteh v. Eat Just, Inc. from the Superior Court of Alameda (Case No. 26CV172997) to the Northern District of California (Case No. 4:26-cv-02972). The removal transfers jurisdiction from state to federal court. The $405 filing fee was paid.

Removes notification requirement for Tamiflu, Relenza prescribing

The Northern Ireland Department of Health has amended regulations to remove the notification requirement for prescribing influenza antivirals Oseltamivir (Tamiflu) and Zanamivir (Relenza) under general medical services contracts. The amendment to Schedule 2 of the 2004 Regulations takes effect 1st May 2026, allowing year-round prescribing of these treatments when other specified conditions are met.